|1.||Di Marzo, V: 1 article (10/2001)|
|2.||Mascolo, N: 1 article (10/2001)|
|3.||Capasso, F: 1 article (10/2001)|
|4.||Capasso, R: 1 article (10/2001)|
|5.||Pinto, L: 1 article (10/2001)|
|6.||Bisogno, T: 1 article (10/2001)|
|7.||Izzo, A A: 1 article (10/2001)|
|8.||Esposito, G: 1 article (10/2001)|
|9.||Fezza, F: 1 article (10/2001)|
|10.||Iuvone, T: 1 article (10/2001)|
12/11/1995 - "Here we report the partial characterisation and purification of 'anandamide amidohydrolase' from membrane fractions of N18 neuroblastoma cells, and provide evidence for a further and previously unsuspected role of this enzyme. "
12/11/1995 - "Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma 'anandamide amidohydrolase'."
02/03/1997 - "Mammalian brain as well as mouse neuroblastoma (N18TG2) and rat basophilic leukaemia (RBL) cells were previously shown to contain "anandamide amidohydrolase', a membrane-bound enzyme sensitive to serine and cysteine protease inhibitors and catalyzing the hydrolysis of the endogenous cannabimimetic metabolite, anandamide (arachidonoyl-ethanolamide). "
10/01/2001 - "1. We have studied the effect of cannabinoid agonists (CP 55,940 and cannabinol) on intestinal motility in a model of intestinal inflammation (induced by oral croton oil in mice) and measured cannabinoid receptor expression, endocannabinoids (anandamide and 2-arachidonylglycerol) and anandamide amidohydrolase activity both in physiological and pathophysiological states. "
|3.||Cannabinoid Receptors (Cannabinoid Receptor)
|4.||Cysteine Proteinase Inhibitors